Stock Events

Stock Events

TAO Synergies 

$3.38
27
+$0.16+4.97% Wednesday 20:00
+$0.01+0.3%Wednesday 23:30After hours

Statistics

Day High
3.42
Day Low
3.42
52W High
10
52W Low
3.07
Volume
1,258
Avg. Volume
-
Mkt Cap
25.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.06
-1.23
-0.4
0.43
Expected EPS
N/A
Actual EPS
N/A

Financials

-9,724.41%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
299,000Revenue
-29.08MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TAOX. It's not an investment recommendation.
Amazon
4
AMZN
BitMine Immersion Technologies
4
BMNR
Microsoft
3
MSFT
Tesla
3
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap31B
Biogen focuses on neurodegenerative diseases, directly competing with Synaptogenix's Alzheimer's and neurological disorder treatments.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong pipeline in Alzheimer's disease treatments, making it a direct competitor in the neurodegenerative space.
Annovis Bio
ANVS
Mkt Cap78.7M
Annovis Bio is engaged in developing therapies for Alzheimer's and Parkinson's diseases, directly competing with Synaptogenix.
AC Immune SA
ACIU
Mkt Cap247.57M
AC Immune SA specializes in neurodegenerative diseases, including Alzheimer's, competing in the same therapeutic area as Synaptogenix.
Anavex Life Sciences
AVXL
Mkt Cap298.48M
Anavex Life Sciences Corp. focuses on developing drugs for Alzheimer's disease, directly competing in the same field.
Arbutus Biopharma
ABUS
Mkt Cap923.95M
Arbutus Biopharma Corporation, though primarily focused on antiviral drugs, has ventured into neurodegenerative diseases, positioning it as a potential competitor.

About

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Show more...
CEO
Joshua N. Silverman
Employees
4
Country
United States
ISIN
US87167T3005

Listings

XNAS
US
TAOX
BOATS
BOATS
TAOX.BOATS

0 Comments

Share your thoughts

FAQ

What is TAO Synergies stock price today?▼
The current price of TAOX is $3.38 USD — it has increased by +4.97% in the past 24 hours. Watch TAO Synergies stock price performance more closely on the chart.
What is TAO Synergies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange TAO Synergies stocks are traded under the ticker TAOX.
Is TAO Synergies stock price growing?▼
TAOX stock has fallen by -2.87% compared to the previous week, the month change is a -5.59% fall, over the last year TAO Synergies has showed a -51.23% decrease.
What is TAO Synergies market cap?▼
Today TAO Synergies has the market capitalization of 25.26M
When is the next TAO Synergies earnings date?▼
TAO Synergies is going to release the next earnings report on December 02, 2026.
What is TAO Synergies revenue for the last year?▼
TAO Synergies revenue for the last year amounts to 299,000 USD.
What is TAO Synergies net income for the last year?▼
TAOX net income for the last year is -29.08M USD.
How many employees does TAO Synergies have?▼
As of August 20, 2026, the company has 4 employees.
In which sector is TAO Synergies located?▼
TAO Synergies operates in the Health & Wellness sector.
When did TAO Synergies complete a stock split?▼
The last stock split for TAO Synergies was on April 05, 2024 with a ratio of 1:25.
Where is TAO Synergies headquartered?▼
TAO Synergies is headquartered in NEW YORK, United States.